FDA.reportPublic FDA data

Cotempla XR-ODT 8.6 MG Extended Release Disintegrating Oral Tablet

RxCUI
1926855
RxNorm name
Cotempla XR-ODT 8.6 MG Extended Release Disintegrating Oral Tablet
Display name
Cotempla XR-ODT 8.6 MG Extended Release Disintegrating Oral Tablet
Full name
Cotempla XR-ODT 8.6 MG Extended Release Disintegrating Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
33f70f58-c871-42c8-8adb-345caeafefcdCotempla XR-ODT 8.6 MG Extended Release Disintegrating Oral Tablet [PSN] · methylphenidate 8.6 MG Disintegrating Oral Tablet [Cotempla] [SBD] · Cotempla 8.6 MG Disintegrating Oral Tablet [SY]315These highlights do not include all the information needed to use COTEMPLA XR-ODT safely and effectively. See full prescribing information for COTEMPLA XR-ODT. COTEMPLA XR-ODT (methylphenidate extended-release orally disintegrating tablets), CII Initial U.S. Approval: 195520250924